Association Between β‐Adrenoreceptor Agonists and Antagonists and Parkinson's Disease: Systematic Review and Meta‐Analysis

Documenti analoghi

• Core Concepts in Pharmacoepidemiology: Quantitative Bias Analysis
  di: Jeremy P. Brown, et al.
  Pubblicazione: (2024)
• The Risk of Hypothyroidism With the Use of GLP ‐1 Receptor Agonists in Saudi Arabia
  di: Almaha Alfakhri, et al.
  Pubblicazione: (2026)
• Determining Drug Exposure Based on Medication Dispensing Data: A Validation Study of Vitamin K Antagonist Treatment Episodes Against INR Records
  di: Eva K. Kempers, et al.
  Pubblicazione: (2025)
• Glucagon‐like Peptide‐1 Receptor Agonists in Asthma Exacerbations: An Application of High‐Dimensional Iterative Causal Forest to Identify Subgroups
  di: Tiansheng Wang, et al.
  Pubblicazione: (2025)
• Comparative Risk for Neuropsychiatric Events in Leukotriene Receptor Antagonist vs. Inhaled Corticosteroid in Children With Asthma: A Nationwide Observational Study With a Complementary Analysis Using Natural Language Processing
  di: Subin Kim, et al.
  Pubblicazione: (2025)